EW vs NEXT · P/E 47, rev $1.39B vs $2.81B cap
Edwards Lifesciences Corp (EW) versus Nextdecade Corp (NEXT) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Nextdecade Corp (NEXT) is a oil & gas equipment & services company listed on US.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported NEXT revenue for 2025-12-31 was $0. Net income was -$429.6M. NEXT currently screens at market cap $2.81B.
EW currently screens at market cap $49.91B and trailing P/E 46.9. NEXT currently screens at market cap $2.81B.
Not investment advice. Open the EW and NEXT stock pages for the full models.
Not investment advice.